Fund a Endowed Chair

Regaining the upper hand over antibiotic resistance before it is too late

Anti-infectives & Antimicrobial resistance

Giving ourselves a fighting chance in the global race against time to protect public health.

What is at stake

Antibiotics are among the greatest advances in modern medicine. They have saved millions of lives by treating infections that were once fatal, and today they make possible a wide range of medical interventions, from surgery and cancer treatment to the care of extremely premature babies.

Yet antimicrobial resistance threatens this progress. The UN forecasts 10 million deaths a year worldwide by 2050 as a result. Investment is therefore needed in new antibiotic compounds to tackle resistant bacteria, and in prevention strategies (safer surfaces, dressings, implants and medical devices). Prevention and innovation will help combat antimicrobial resistance, reduce hospital-acquired infections, and preserve the effectiveness of antibiotics for future generations.

 

Strasbourg, a unique ecosystem

Prevention and treatment: Strasbourg has a comprehensive range of technologies to combat infection, covering both prevention and treatment. In terms of prevention: bactericidal surfaces and polymers, graphene-based materials with antiviral and antibacterial properties, and encapsulation techniques that release an active ingredient exactly when it is required.

In terms of treatment: the design of new classes of antibiotics and of antimicrobial peptides to tackle bacteria that have become resistant. It is on this foundation — preventing as much as treating — that the chair's ambition will be based.

Donation DONATIONS MAKE A DONATION